Global Pet Diabetes Care Market Size (2024 - 2029)

The pet diabetes care market is experiencing growth driven by an increasing prevalence of diabetes in pets, rising pet adoption rates, and a growing pet population. The market's expansion is supported by the significant number of pet animals, particularly dogs and cats, which contributes to the substantial market size. However, challenges such as the high cost of diabetic medications and potential side effects of treatments pose constraints on market growth. The COVID-19 pandemic had a notable impact on the market, affecting veterinary services and routine check-ups, which in turn influenced the prevalence of diabetes in pets.

Market Size of Global Pet Diabetes Care Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Pet Diabetes Care Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 2.12 Billion
Market Size (2029) USD 2.88 Billion
CAGR (2024 - 2029) 6.22 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Pet Diabetes Care Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Pet Diabetes Care Market Analysis

The Global Pet Diabetes Care Market size is estimated at USD 2.12 billion in 2024, and is expected to reach USD 2.88 billion by 2029, growing at a CAGR of 6.22% during the forecast period (2024-2029).

COVID-19 had affected the pet diabetes market significantly. The COVID-19 pandemic imposed hurdles and concerns in the global pet animal health sector, including decreased marketing and sales efforts, reduced people visiting veterinary clinics, cancellation of regular pet check-ups, and fewer instances of insulin administration in veterinary facilities. As per the article published in 2021 under the title 'Diabetes among dogs increased by 10-20% during pandemic: Vets', cases of diabetes in dogs have increased 10-20% during COVID-19. Due to the increased lockdown and restrictions, there was a lack of routine checkups which lead to more cases of diabetes in dogs. Hence COVID-19 had a notable impact in the pet diabetic care market.

The major factors for the growth of the market include the rising prevalence of diabetes in pet animals, an increase in pet adoption, and the growing pet population. For instance, as per the American Pet Products Association's 2021-2022 National Pet Owners Survey, 69 million United States Household has a dog as a pet and 45.3 million households has a cat as a pet. The past few years have observed a significant rise in the adoption of animals, including dogs and cats as the favorite companions of human beings. Dogs and cats are not only the most preferred pets but are also known to improve the physical and mental health of humans. The developed countries have the leading position in companion animal ownership, owing to several factors, like favorable economic conditions, among others.

Furthermore, according to the American Pet Products Association's 2021-2022 National Pet Owners Survey, the basic annual expenses for Dogs and Cats for surgical vets are USD 458 and USD 201 respectively. Thus, the rise in adoption of pet animals is expected to increase the spending on health care needs of these animals which would in turn expected to boost the growth of the market over the forecast period.

Therefore, the market studied has a remarkable size, supported by the high population of pet animals, particularly cats and dogs. Hence, the increase in pet adoption has helped in driving the pet diabetes market over the forecast period. However, the high cost of diabetic medication and side effects relating to medicines and insulin restrain the market growth.

Pet Diabetes Care Industry Segmentation

As per the scope of the report, diabetes is a chronic disease that can also affect dogs and cats. Diabetes is more common in older pets, but it can also occur in younger or pregnant pets. Pet Diabetes Care market includes therapies that are used to treat or alleviate diabetes in animals or devices used to track or monitor blood glucose and administer insulin in animals. The Pet Diabetes Care Market is segmented by Drug Type (Insulin Therapy, Oral Medication), Device Type (Glucose Monitoring Devices, Insulin Delivery Devices), Animal Type (Canine, Feline), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Drug Type
Insulin Therapy
Oral Medication
By Device Type
Glucose Monitoring Devices
Insulin Delivery Devices
By Animal Type
Canine
Feline
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Pet Diabetes Care Market Size Summary

The pet diabetes care market is experiencing significant growth, driven by the increasing prevalence of diabetes among pet animals, a rise in pet adoption, and a growing pet population. The market has been impacted by the COVID-19 pandemic, which led to a decrease in routine veterinary visits and a rise in undiagnosed diabetes cases due to lockdowns. Despite these challenges, the market is poised for expansion, supported by the high ownership of companion animals, particularly dogs and cats, in developed countries. The demand for pet diabetes care is further bolstered by the rising healthcare expenditures for pets, as owners increasingly prioritize their pets' health and well-being.

In North America, the market is expected to witness robust growth due to rising pet adoption rates and increased spending on pet healthcare. The region's pet insurance market is also expanding, with a significant number of pets insured, particularly dogs. Key players in the market are focusing on strategic initiatives such as mergers, acquisitions, and research to enhance their market presence. Innovations in diabetes management, including the development of continuous glucose monitoring systems and novel insulin treatments, are expected to create new opportunities for market players. Despite the high cost of diabetic medications and potential side effects, the market is anticipated to grow, driven by advancements in research and development and the increasing incidence of diabetes in pets.

Explore More

Global Pet Diabetes Care Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalence of Diabetes and Obesity in Pet Animals

      2. 1.2.2 Increase in Pet Adoption

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Diabetes Medications

      2. 1.3.2 Adverse Reaction of Medications

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Drug Type

      1. 2.1.1 Insulin Therapy

      2. 2.1.2 Oral Medication

    2. 2.2 By Device Type

      1. 2.2.1 Glucose Monitoring Devices

      2. 2.2.2 Insulin Delivery Devices

    3. 2.3 By Animal Type

      1. 2.3.1 Canine

      2. 2.3.2 Feline

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Pet Diabetes Care Market Size FAQs

The Global Pet Diabetes Care Market size is expected to reach USD 2.12 billion in 2024 and grow at a CAGR of 6.22% to reach USD 2.88 billion by 2029.

In 2024, the Global Pet Diabetes Care Market size is expected to reach USD 2.12 billion.

Pet Diabetes Care Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)